Arrowstreet Capital’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,293,289
| Closed | -$4.07M | – | 2647 |
|
|
2020
Q3 | $4.07M | Buy |
1,293,289
+524,208
| +68% | +$1.65M | 0.01% | 1239 |
|
|
2020
Q2 | $2.24M | Buy |
769,081
+752,481
| +4,533% | +$2.19M | ﹤0.01% | 1427 |
|
|
2020
Q1 | $47K | Sell |
16,600
-177,400
| -91% | -$502K | ﹤0.01% | 1824 |
|
|
2019
Q4 | $630K | Sell |
194,000
-204,950
| -51% | -$666K | ﹤0.01% | 1445 |
|
|
2019
Q3 | $862K | Sell |
398,950
-1,426,431
| -78% | -$3.08M | ﹤0.01% | 1198 |
|
|
2019
Q2 | $5.73M | Sell |
1,825,381
-748,902
| -29% | -$2.35M | 0.01% | 613 |
|
|
2019
Q1 | $9.58M | Buy |
2,574,283
+2,457,178
| +2,098% | +$9.14M | 0.02% | 572 |
|
|
2018
Q4 | $340K | Buy |
+117,105
| New | +$340K | ﹤0.01% | 1173 |
|
|
2017
Q2 | – | Sell |
-131,200
| Closed | -$298K | – | 1483 |
|
|
2017
Q1 | $298K | Buy |
+131,200
| New | +$298K | ﹤0.01% | 1151 |
|
|
2016
Q4 | – | Sell |
-365,050
| Closed | -$1.22M | – | 2954 |
|
|
2016
Q3 | $1.22M | Sell |
365,050
-50,808
| -12% | -$170K | ﹤0.01% | 1028 |
|
|
2016
Q2 | $1.31M | Sell |
415,858
-165,111
| -28% | -$519K | ﹤0.01% | 947 |
|
|
2016
Q1 | $1.94M | Buy |
580,969
+62,969
| +12% | +$210K | 0.01% | 819 |
|
|
2015
Q4 | $1.83M | Buy |
518,000
+448,200
| +642% | +$1.59M | 0.01% | 823 |
|
|
2015
Q3 | $351K | Buy |
+69,800
| New | +$351K | ﹤0.01% | 1170 |
|
|
2014
Q2 | – | Sell |
-943,334
| Closed | -$7.84M | – | 1368 |
|
|
2014
Q1 | $7.84M | Sell |
943,334
-892,103
| -49% | -$7.41M | 0.05% | 347 |
|
|
2013
Q4 | $15.5M | Buy |
1,835,437
+526,060
| +40% | +$4.44M | 0.08% | 221 |
|
|
2013
Q3 | $10.4M | Sell |
1,309,377
-117,947
| -8% | -$940K | 0.07% | 257 |
|
|
2013
Q2 | $11M | Buy |
+1,427,324
| New | +$11M | 0.08% | 208 |
|